Twinning: A rewarding scenario for development of oncology services in transitional countries

Pediatric Blood and Cancer

Volumn 45, Issue 2, 2005, Pages 103-106

  Veerman, A J P ^a   Sutaryo, ^b   Sumadiono, ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTOSTATIC AGENT; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CENTER; CHILDHOOD CANCER; CHILDHOOD MORTALITY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG COST; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INDONESIA; NETHERLANDS; NOTE; PRIORITY JOURNAL; TWINNING PROGRAM;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD HEALTH SERVICES; DEVELOPING COUNTRIES; EDUCATION, PROFESSIONAL; HEALTH TRANSITION; HUMANS; INDONESIA; INTERNATIONAL COOPERATION; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MEDICAL ONCOLOGY; NETHERLANDS; PEDIATRICS; RESEARCH;

EID: 22244479369     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20390     Document Type: Note

References (14)

1. Margrath IT, Petrelli S, Gaad-El-Mawa N, et al. Pediatric oncology in countries with limited resources. In: Pizzo PA, Poplack DG editors. Principles and practice of pediatric oncology, 3rd edn. Philadelphia: Lippincott-Raven; 1997. pp 1395-1420.
2. Masera G, Baez F, Biondi A, et al. North-South twinning in paediatric haemato-oncology: The La Mascota programme, Nicaragua. Lancet 1998;352:1923-1926.
3. Chandy M. Childhood acute lymphoblastic leukaemia in India: An approach to management in a tree-tier society. Med Pediatr Oncol 1995;25:197-203.
4. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471-2475.
5. Shearer D, Pui C-H. The walls of a spacious room. Med Pediatr Oncol 2001;36:312-313.
6. Naafs-Wilstra M, Barr R, Greenberg C, et al. Pediatric oncology in developing countries: Development of an alliance of stakeholders. Med Pediatr Oncol 2001;36:305-309.
7. Veerman AJP, Haehlen K, Kamps WA, et al. High cure rate with a moderately intensive treatment regimen in non-high risk childhood acute lymphoblastic leukemia: Results of protocol ALL-VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996; 14:911-918.
8. Schrappe M, Camitta B, Pui CH, et al. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 2000;14:2193-2194.
9. Wagner HP. Alliances in pediatric oncology: Where do we go from here? Med Pediatr Oncol 2001;36:310-311.
10. Agarwal B, Dalvi R. Treatment of childhood leukemias in under-privileged countries. In: Pui C-H, editor. Current clinical oncology: Treatment of acute leukemias: New directions for clinical research. Totowa: Humana Press; 2003. pp 321-329.
11. Sumadiono XX, Sutaryo XX, Veerman AJP. Randomized double blind trial of fluoroquinolone prophylaxis for bacterial infection during the induction and reinduction treatment in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 2001;37:291 (abstract).
12. Sumadiono S, Sutaryo XX, Veerman AJP. Preliminary report of the protocol of Wijaya Kusuma Acute Lymphoblastic Leukemia 2000 (WK-ALL-2000) in Indonesia. Med Pediatr Oncol 2002;39:389 (abstract).
13. Sutaryo XX, Sumadiono M, Veerman AJP. Experiences with the Wijaya Kusuma ALL 2000 protocol in Yogyakarta, Indonesia. Med Pediatr Oncol 2003;41:248 (abstract).
14. Masera G, Biondi A. How to confront the problem of treatment of childhood leukemias in underprivileged countries. In: Pui C-H, editor. Current clinical oncology: Treatment of acute leukemias: New directions for clinical research. Totowa: Humana Press; 2003. pp 331-335.